WHO launches COVID-19 pool with 37 countries
29-05-2020
Costa Rica asks WHO to create voluntary COVID-19 IP pool
26-03-2020
17-11-2020
Blue Planet Studio / Shutterstock.com
In response to the surge of COVID-19 infections worldwide, 18 generic drug makers have pledged to join the effort by the Medicines Patent Pool (MPP) to accelerate global access to effective COVID-19 treatments via a pool for voluntary product licences.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Adcock Ingram, Arene Life Sciences, Aurobindo, Beximco, Celltrion, Desano, Hetero, Lupin, Langua Pharma, Macleods, Mangalam Drugs & Drugs, Micro Labs